PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
2011

New Potential Drugs for Spinal Cord Injury

Sample size: 240 publication 10 minutes Evidence: moderate

Author Information

Author(s): Paterniti Irene, Mazzon Emanuela, Gil Carmen, Impellizzeri Daniela, Palomo Valle, Redondo Myriam, Perez Daniel I., Esposito Emanuela, Martinez Ana, Cuzzocrea Salvatore

Primary Institution: University of Messina, Messina, Italy

Hypothesis

PDE7 inhibitors can reduce neuroinflammation and tissue damage in spinal cord injury.

Conclusion

PDE7 inhibitors S14 and VP1.15 show promise as potential drug candidates for treating spinal cord injury by reducing inflammation and tissue damage.

Supporting Evidence

  • Treatment with S14 and VP1.15 significantly reduced spinal cord inflammation.
  • Both drugs improved motor function in mice after spinal cord injury.
  • S14 and VP1.15 were able to cross the blood-brain barrier.
  • Inflammatory cytokines TNF-α and IL-1β levels were significantly reduced by treatment.
  • Histological analysis showed less tissue damage in treated mice compared to controls.

Takeaway

Scientists found two new drugs that can help heal the spinal cord after an injury by reducing swelling and helping the nerves work better.

Methodology

The study used a mouse model of spinal cord injury and evaluated the effects of PDE7 inhibitors on inflammation and tissue damage.

Potential Biases

Potential bias in the selection of treatment groups and outcome assessments.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

Male adult CD1 mice (25–30 g).

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pone.0015937

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication